Description
Product details
ATOVASTRIN CV 40/75 Atorvastatin (40mg), Clopidogrel (75mg) ATOVASTRIN CV 40/75 Atorvastatin Classification: Atorvastatin belongs to the statin class of medications. Primary Use: It is used to lower blood levels of bad cholesterol (LDL-C) and triglycerides, while increasing levels of good cholesterol (HDL-C). Mechanism of Action: Atorvastatin works by inhibiting the enzyme HMG-CoA reductase in the liver, which plays a crucial role in cholesterol synthesis. This inhibition leads to a decrease in cholesterol production, thereby lowering the total cholesterol in the bloodstream. Benefits: By reducing LDL-C and triglycerides, atorvastatin decreases the risk of plaque formation in arteries, subsequently reducing the risk of heart attacks, strokes, and other cardiovascular diseases. Clopidogrel Classification: Clopidogrel is an antiplatelet medication. Primary Use: It is prescribed to prevent blood clots in patients who have experienced heart attacks, strokes, or have other forms of cardiovascular disease that put them at high risk of clot-related events. Mechanism of Action: Clopidogrel inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor, which is essential for platelet activation and aggregation. This inhibition reduces the risk of clot formation. Benefits: By preventing platelet aggregation, clopidogrel lowers the risk of further cardiovascular events in individuals with a history of these conditions. ATOVASTRIN CV 40/75 Rationale: The combination targets two critical pathways in cardiovascular disease progression: atherosclerosis (through lipid management with atorvastatin) and thrombosis (through antiplatelet action with clopidogrel). Evidence: Clinical studies have shown that the concurrent use of statins like atorvastatin with antiplatelet agents such as clopidogrel can provide synergistic benefits in reducing the risk of cardiovascular events. Interactions: While generally well-tolerated, the combination should be monitored for potential drug interactions and adverse effects. For example, some statins may impact the efficacy of clopidogrel, although atorvastatin is less likely to have a significant effect compared to some other statins. Side Effects: Patients should be aware of potential side effects, including muscle-related symptoms from atorvastatin and increased bleeding risk from clopidogrel. Individualization of Therapy: Treatment with atorvastatin and clopidogrel should be tailored to the individual's risk factors, health status, and specific cardiovascular risk profile. For further information: Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 Buy Now: https://www.sterisonline.com/product/atovastrin-cv-40-75-134205
